Search for dissertations about: "Role of EGFR in head and neck cancer"
Showing result 1 - 5 of 6 swedish dissertations containing the words Role of EGFR in head and neck cancer.
-
1. p63 and potential p63 targets in squamous cell carcinoma of the head and neck
Abstract : Squamous cell carcinoma of the head and neck (SCCHN), the 6th most common cancer worldwide, has a low 5-year survival. Disease as well as treatment often causes patients severe functional and aesthetic problems. READ MORE
-
2. Rules of engagement - Regulation of complement response in tissue
Abstract : Always in motion and probing for danger, complement proteins are found in every space and notch of the body. Their omnipresence combined with an ability to wreak havoc when activated, mandates a strong leash! The how, when, and where to unleash or constrain the complement response remain partly answered questions, despite the significant progress made in the field in the past 100 years. READ MORE
-
3. Inverted papilloma and sinonasal malignancies in Sweden
Abstract : Background: Sinonasal malignancies (SNMs) are rare and in Sweden they account for approximately 0,1% of all malignancies and 5% of all head and neck malignancies. Apart from sinonasal malignant melanoma (SNMM), their incidence has been reported to decrease since 1960 while the survival rates have remained rather stable during the same time-period. READ MORE
-
4. Altered cell metabolism and migration in nasopharyngeal carcinoma
Abstract : Nasopharyngeal carcinoma (NPC) is a subtype of head and neck cancer, originating from the nasopharynx. The etiology of NPC is considered a complex interaction between Epstein–Barr virus (EBV) infection, genetic susceptibility, environmental factors, and lifestyle factors. NPC has the highest metastasis rate among all head and neck cancers. READ MORE
-
5. Predictive and prognostic biomarkers in oral tongue squamous cell carcinoma
Abstract : Oral tongue squamous cell carcinoma (OTSCC) is an aggressive disease frequently associated with poor prognosis due to the high risk of regional failure and mortality rates have been practically unchanged in Sweden the last fifty years, despite advancements in both diagnostics and treatment. Today we lack means to assess the biological aggressiveness of each individual tumor which varies largely. READ MORE